Sale of Securities

Dianthus Therapeutics, Inc. /DE/ Filed 2026-08-07 Acc 0001950047-26-007793

Documents 1

2026-08-07 144 Sale of Securities
2026-08-07 144 Sale of Securities
2026-08-07 144 Sale of Securities
2026-08-07 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-08-07 SCHEDULE 13G Statement of Beneficial Ownership
2026-08-07 4 CEO AND PRESIDENT sold 166,000 shares at an average $108.11 ($17,945,451)
2026-07-09 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…